571186-93-1,
imatinib related substance b,
Imatinib (Piperidine)-N,N-dioxide,
iMatinibrelatedsubstanceB,
4-[(4-Methyl-1,4-dioxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,
A1-01892,
MFKGVMIUOYNDCV-UHFFFAOYSA-N,
Imatinib Mesylate Impurity B,
SCHEMBL3267642,
DTXSID20857871,
ZINC77301188,
AKOS025243845,
ACN-027560,
RD-0071,
TRA-0206320,
FT-0689648,
J-514202,
4-[(4-Methyl-1,4-dioxido-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide,
4-[(4-Methyl-1,4-dioxo-1lambda~5~,4lambda~5~-piperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide,
4-[(4-Methyl-1.4-dioxido-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide,
Benzamide, 4-[(4-methyl-1,4-dioxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,
CS-T-56609,